MOBILE PATH
LIVE

Serial Number

88276625

Owner

Essenlix Corporation

Attorney

Xiongying Tu

First Use Date

Jul 21, 2022

Filing Date

Jan 25, 2019

Add to watchlist:

No watchlists yet
View on USPTO

MOBILE PATH Trademark

Serial Number: 88276625 • Registration: 6859760

MOBILE PATH is a trademark filed by Essenlix Corporation on January 25, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Essenlix Corporation (147 trademarks)

7 Foulet Dr
Princeton, CA 08540

Entity Type: 03

Trademark Details

Filing Date

January 25, 2019

Registration Date

September 27, 2022

First Use Anywhere

July 21, 2022

First Use in Commerce

July 21, 2022

Published for Opposition

November 26, 2019

Goods & Services

Assays for research purposes; Biological and chemical reagents used for non-medical purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits for laboratory or research use in the field of personal wellness; Biological and chemical test kits for laboratory or research use for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services in the field of digital healthcare services; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing, diagnostic testing, and wellness services, all in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue- based diagnostic testing, cytology, and cell-based testing; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample

Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 3, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 3, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 3, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 3, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 3, 2026 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 27, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 20, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 19, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 9, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 9, 2022 AITU
USE AMENDMENT FILED
Jul 21, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 21, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 22, 2022 EXRA
SOU EXTENSION 4 GRANTED
Jan 20, 2022 EX4G
SOU EXTENSION 4 FILED
Jan 20, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 20, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 23, 2021 EXRA
SOU EXTENSION 3 GRANTED
Jul 21, 2021 EX3G
SOU EXTENSION 3 FILED
Jul 21, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 21, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 19, 2021 EXRA
SOU EXTENSION 2 GRANTED
Jan 15, 2021 EX2G
SOU EXTENSION 2 FILED
Jan 15, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 15, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 11, 2020 EXRA
SOU EXTENSION 1 GRANTED
Jul 9, 2020 EX1G
SOU EXTENSION 1 FILED
Jul 9, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 9, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 21, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 6, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 18, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 18, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 18, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 18, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 18, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2019 CRFA
ASSIGNED TO LIE
Sep 25, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 18, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 22, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 22, 2019 GNRT
NON-FINAL ACTION WRITTEN
Mar 22, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 17, 2019 NWOS
NEW APPLICATION ENTERED
Jan 29, 2019 NWAP